Interventions for basal cell carcinoma: abridged Cochrane systematic review and grade assessments.

CONCLUSIONS: Surgical interventions have lower recurrence rates and remain the gold-standard for high-risk BCC. Of the non-surgical treatments, topical imiquimod has the best evidence to support its efficacy for low-risk BCC. Priorities for future research include agreement on core outcome measures and studies with longer follow-up. PMID: 33448328 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research